Diagnostic Imaging's Top Five Prostate Imaging Content of 2024

News
Slideshow

Catch up on the most well-viewed prostate imaging content from 2024.

As we come to the end of 2024, we take a look back at the most well-read prostate imaging content with topics ranging from predictive factors for metastatic prostate cancer to the use of prostate MRI for active surveillance and PSMA PET/CT-guided radiotherapy for oligometastatic prostate cancer. Review the slideshow below to see highlighted prostate imaging content from the past year.

Recent Videos
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Related Content
FDA Clears Emerging 3D Ultrasound Technology

FDA Clears Emerging 3D Ultrasound Technology

Jeff Hall
July 2nd 2025
Article

The diagnostic tomographic 3D ultrasound imaging technology PIUR tUS inside will reportedly be available with select GE HealthCare Logiq systems.

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET

Jeff Hall
March 18th 2025
Podcast

In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.

Cardiac MRI Study Affirms Link Between Air Pollution Exposure and Increased Diffuse Myocardial Fibrosis

Cardiac MRI Study Affirms Link Between Air Pollution Exposure and Increased Diffuse Myocardial Fibrosis

Jeff Hall
July 1st 2025
Article

For people with dilated cardiomyopathy and those with initially normal cardiac MRI, each 1 ug/m3 increase in one-year exposure to ambient fine particulate matter with 2.5-um > aerodynamic diameter was associated with significantly more diffuse myocardial fibrosis, according to a recent study.

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

MindMoments: Consensus MRI Guidelines for Multiple Sclerosis

Matt Hoffman
July 3rd 2021
Podcast

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers

FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers

Jeff Hall
June 26th 2025
Article

Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.

FDA Approves Multiple New Indications for the Brain PET Imaging Agent Vizamyl

FDA Approves Multiple New Indications for the Brain PET Imaging Agent Vizamyl

Jeff Hall
June 25th 2025
Article

Expanded indications for the flutemetamol F18 injection include amyloid quantification and monitoring of anti-amyloid treatments.

© 2025 MJH Life Sciences

All rights reserved.